Ownership of Study Data. BMS shall own the Study Data to the extent that it relates solely to the BMS Study Drug (“BMS Study Data”), and Recipient shall own the Study Data to the extent that it relates solely to the Recipient Study Drug (“Recipient Study Data”).
Appears in 1 contract
Sources: Clinical Trial Collaboration and Supply Agreement (Aveo Pharmaceuticals, Inc.)
Ownership of Study Data. BMS shall own the Study Data to the extent that it relates solely to the BMS Study Drug Compound (“BMS Study Data”), and Recipient Checkmate shall own the Study Data to the extent that it relates solely to the Recipient Study Drug Checkmate Compound (“Recipient Checkmate Study Data”).
Appears in 1 contract
Sources: Master Clinical Trial Collaboration Agreement (Checkmate Pharmaceuticals, Inc.)